Advertisement
Subscribe now
Log in
September 28, 2026 15:42
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Ansarada
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
CSR
Swing for the Kids
World News
Tags
KQTD-126
XtalPi files FDA application for intestinal pain drug candidate
September 28, 2026 | 14:20
Technology firm XtalPi submitted an Investigational New Drug application to the US Food and Drug Administration to initiate clinical trials for its gut-restricted inhibitor KQTD-126.
Latest News
Segi Fresh opens refreshed retail store concept in Bidor
Harvard Business Review features Xsight Group AI research study
Chartis Research names Nuix risk infrastructure disruptor in report
Loyalty Juggernaut secures ISO artificial intelligence management certification
Mobile Version